Healthcare Global Enterprises Sustainability Profile
Healthcare Global Enterprises (HCG), headquartered in India, is a leading player in the oncology and healthcare sector. Established in 2001, HCG has made significant strides in providing comprehensive cancer care, with a network of hospitals and clinics across major operational regions in India and beyond. HCG is renowned for its advanced cancer treatment services, including radiation therapy, chemotherapy, and surgical oncology, distinguished by its commitment to personalised patient care and cutting-edge technology. The company has achieved notable milestones, such as being the first to introduce a dedicated cancer hospital in India, solidifying its position as a pioneer in the industry. With a focus on innovation and excellence, HCG continues to enhance its market position, recognised for its high standards of care and successful patient outcomes.
DitchCarbon Score
How does Healthcare Global Enterprises's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Healthcare Global Enterprises's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Healthcare Global Enterprises's reported carbon emissions
In 2024, Healthcare Global Enterprises reported total carbon emissions of approximately 42,803,000 kg CO2e, with Scope 1 emissions at about 981,240 kg CO2e and Scope 2 emissions at approximately 34,088,950 kg CO2e. This represents a significant decrease from 2023, where total emissions were around 63,214,000 kg CO2e, with Scope 1 emissions of about 2,929,130 kg CO2e and Scope 2 emissions of approximately 21,769,000 kg CO2e. Despite these reductions, Healthcare Global Enterprises has not disclosed any Scope 3 emissions data. The company has not set specific reduction targets or climate pledges, as indicated by the absence of documented reduction initiatives or commitments to frameworks such as the Science Based Targets initiative (SBTi). The emissions data is cascaded from the parent company, HealthCare Global Enterprises Limited, through a corporate family relationship with CVC Capital Partners plc, which oversees various sustainability initiatives. As a current subsidiary, Healthcare Global Enterprises is expected to align with broader corporate sustainability goals, although specific targets have not been established at this level.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 2,929,130 | 000,000 |
| Scope 2 | 21,769,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Healthcare Global Enterprises's Industry?
How Carbon Intensive is Healthcare Global Enterprises's Location?
Healthcare Global Enterprises's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Healthcare Global Enterprises has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
